Nash, R. A., Bowen, J. D., McSweeney, P. A., Sullivan, K. M., Pavletic, Z. S., Maravilla, K. R., … Kraft, G. H. (2002). Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT): 2 year follow-up. In BLOOD (Vol. 100, pp. 864A-864A). PHILADELPHIA, PENNSYLVANIA: AMER SOC HEMATOLOGY.

Nash, R. A., J. D. Bowen, P. A. McSweeney, K. M. Sullivan, Z. S. Pavletic, K. R. Maravilla, J. Al-Omaishi, et al. “Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT): 2 year follow-up.” In BLOOD, 100:864A-864A. AMER SOC HEMATOLOGY, 2002.

Nash RA, Bowen JD, McSweeney PA, Sullivan KM, Pavletic ZS, Maravilla KR, et al. Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT): 2 year follow-up. In: BLOOD. AMER SOC HEMATOLOGY; 2002. p. 864A-864A.

Nash, R. A., et al. “Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT): 2 year follow-up.” BLOOD, vol. 100, no. 11, AMER SOC HEMATOLOGY, 2002, pp. 864A-864A.

Nash RA, Bowen JD, McSweeney PA, Sullivan KM, Pavletic ZS, Maravilla KR, Al-Omaishi J, Corboy JR, Derrington D, DiPersio J, Georges GE, Gooley T, Holmberg LA, LeMaistre CF, Openshaw H, Ryan K, Sunderhaus J, Storek J, Zunt J, Storb R, Kraft GH. Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT): 2 year follow-up. BLOOD. AMER SOC HEMATOLOGY; 2002. p. 864A-864A.